Omni Bio Pharmaceutical, Inc. Hosts Panel On Alpha-1-antitrypsin At 8th World Congress On Trauma, Shock, Inflammation And Sepsis
Source: Medical News Today
Friday 12th March, 2010
Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTCBB: OMBP) announced that its acting Chief Executive Officer, Dr Charles A.
Dinarello, will moderate a panel at the 8th World Congress on Trauma, Shock, ... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story